Eve Burstein
Stock Analyst at Bernstein
(1.42)
# 1,061
Out of 4,479 analysts
13
Total ratings
50%
Success rate
-10.78%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.28 | +95.31% | 2 | Apr 18, 2024 | |
| NTRA Natera | Upgrades: Outperform | $120 | $110.70 | +8.40% | 2 | Apr 5, 2024 | |
| TMO Thermo Fisher | Downgrades: Market Perform | n/a | $533.93 | - | 2 | Jan 8, 2024 | |
| EXAS Exact Sciences | Initiates: Outperform | $83 | $43.17 | +92.26% | 1 | Sep 28, 2023 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $20.58 | +6.90% | 1 | Sep 28, 2023 | |
| GH Guardant Health | Initiates: Outperform | $34 | $28.87 | +17.77% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $105.51 | +5.20% | 1 | Sep 28, 2023 | |
| WAT Waters | Initiates: Market Perform | $280 | $284.49 | -1.58% | 1 | Sep 28, 2023 | |
| A Agilent Technologies | Initiates: Market Perform | $123 | $125.78 | -2.21% | 1 | Sep 28, 2023 | |
| RVTY Revvity | Initiates: Outperform | $133 | $102.01 | +30.38% | 1 | Sep 28, 2023 |
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.28
Upside: +95.31%
Natera
Apr 5, 2024
Upgrades: Outperform
Price Target: $120
Current: $110.70
Upside: +8.40%
Thermo Fisher
Jan 8, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $533.93
Upside: -
Exact Sciences
Sep 28, 2023
Initiates: Outperform
Price Target: $83
Current: $43.17
Upside: +92.26%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $20.58
Upside: +6.90%
Guardant Health
Sep 28, 2023
Initiates: Outperform
Price Target: $34
Current: $28.87
Upside: +17.77%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $105.51
Upside: +5.20%
Waters
Sep 28, 2023
Initiates: Market Perform
Price Target: $280
Current: $284.49
Upside: -1.58%
Agilent Technologies
Sep 28, 2023
Initiates: Market Perform
Price Target: $123
Current: $125.78
Upside: -2.21%
Revvity
Sep 28, 2023
Initiates: Outperform
Price Target: $133
Current: $102.01
Upside: +30.38%